Technology Holdings, Inc. (NASDAQ:CELZ), a clinical-stage biotechnology firm, has announced a strategic collaboration with Greenstone Biosciences Inc. to utilize Artificial Intelligence (AI) in ...
Creative Medical Technology (CELZ) announced an expanded agreement with Greenstone Biosciences to leverage Artificial Intelligence in further developing its human induced pluripotent stem cell ...
PHOENIX, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical”), a clinical-stage biotechnology company advancing regenerative ...
(RTTNews) - Creative Medical Technology Holdings, Inc. (CELZ), a clinical-stage biotechnology company, has expanded its partnership with Greenstone Biosciences Inc. to enhance the development of ...
FDA approval under expanded access for Creative Medical. CELZ-201, a pioneering cell-based program, targets abnormal glucose tolerance to prevent Type 1 diabetes. Creative Medical Technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback